Webinars and events

New guidelines for the viral safety evaluation of biotechnology products from the International Council for Harmonisation (ICH) recommend replacing multiple in vivo and in vitro assays with next-generation sequencing (NGS) to maintain good manufacturing practices.

If that sounds like a lot, we’ve got you covered. In this webinar, we’ll explore how you can easily apply NGS analysis to GxP with the QIAGEN CLC Genomics platform. Make compliance intrinsic to your workflow and ensure product quality, data integrity and patient safety.

You’ll learn how to:

• Assess biosafety, ensure integrity and perform quality control in the biotech industry with NGS
• Implement and maintain GxP with the QIAGEN CLC Genomics platform
• Add your existing applications and extend their use through the CLC interface